Atorvastatin Gets New Indications

Number of posts : 112 Registration date : 2006-12-09

Atorvastatin Gets New Indications in Established Cardiovascular Disease

The FDA has approved five new indications for atorvastatin (Lipitor) in patients with cardiovascular disease, according to its manufacturer.

The company said in a press release Wednesday that atorvastatin has now been approved for reducing the risks for nonfatal myocardial infarctions, fatal and nonfatal strokes, certain types of heart surgery, hospitalization for heart failure, and angina in patients with established coronary heart disease. This is the first statin to be approved for reducing the risk for hospitalization because of heart failure, according to the press release.